logo
A genetic disorder turned life upside down for this Texas woman—until she turned to a Pune-based doctor

A genetic disorder turned life upside down for this Texas woman—until she turned to a Pune-based doctor

Indian Express18-05-2025

Daily life had become a huge battle for Alyssa Pettigrew, a 37-year-old accountant from Texas.
Pain coupled with embarrassment at her medical condition and a pregnancy that complicated it even more was more than what the woman had bargained for when she went in for a genetic test to rule out a family disorder.
Her worst nightmare came true as the results came positive, and thus began a long journey of trials.
Her rare genetic disorder needed the removal of her colon to prevent cancer.
'My mother and a few cousins in the family have this disorder, and realising the possibility that I could inherit it, I did a genetic test and was diagnosed with the disorder. I had more than 1,000 polyps,' she recalled.
With most of her large intestine gone, she needed a new way for waste to exit her body.
Surgeons performed a J-pouch procedure—a common reconstructive surgery for patients in her situation.
Unfortunately, Alyssa developed a recto-vaginal fistula, a distressing and serious condition where an abnormal connection forms between the rectum and vagina.
'It was incredibly painful and humiliating,' Alyssa recalled. 'I had three openings in my anus that were communicating with my vagina. I was passing stool through my vagina. It felt like an endless cycle of surgeries and disappointments,' she said.
'Familial adenomatous polyposis' is a rare genetic condition, and it is estimated to affect about one in 8,000 people.
There is a high risk of developing colorectal cancer, and while Alyssa had undergone lifesaving surgery, her condition had worsened due to several complications.
She soon turned to an international community on Facebook, Fistula Support Group, where she decided to check out alternative treatment approaches and read about a novel approach, distal laser proximal ligation surgery, that Dr Ashwin Porwal, a Pune-based colo-rectal surgeon and founder of Healing Hands Clinic, has pioneered.
She admits to never having heard about the treatment, but reading success stories from several patients across more than 20 countries in the support group gave her hope.
'It felt like my last chance at a normal life,' she said and decided to fly down to Pune.
Pregnancy complicates condition
When Alyssa arrived in India in 2023, her case had grown even more complex—she was five months pregnant.
'Administering anaesthesia posed significant risks, and any surgical intervention had to be meticulously planned to ensure the safety of both mother and baby,' Dr Porwal recalled.
'We were dealing with an extremely delicate situation — not only was her fistula highly complex, but we also had to take every precaution to ensure the pregnancy remained unaffected,' Dr Porwal said.
The team proceeded with extreme caution.
Plant-based medications replaced standard pharmaceuticals to ensure the baby's safety, and even anaesthesia was meticulously adjusted to minimise risk.
The use of laser makes debridement (removal of dead, damaged or infected tissue) more effective and takes care of fibrosis associated with the complex fistula.
'After the surgery, efficient drainage from the fistula in the first two to three weeks is the key to success for a cure,' Dr Porwal said.
This is achieved by a timely follow-up planned at five days, two weeks, four weeks and six weeks.
There is no need for daily dressing with DLPL, and the patient can resume work in three to five days,' he added.
As per the Indian Journal of Colorectal Surgery, the DLPL surgery is a safe and effective treatment for complex fistula-in-ano.
According to Dr Porwal, it is a minimally invasive sphincter-saving surgery for complex fistulas.
'Basically it addresses the intersphincteric space, which is the root cause of complex fistula,' said Dr Porwal, who has treated more than 7,000 patients
'The traditional surgery for fistula has a failure rate which can range to 30 per cent, but with DLPL, the failure rate is around 1 per cent,' Dr Porwal said.
After weeks of close monitoring in India, Alyssa was cured from a complex vaginal fistula.
She returned to Texas and later delivered a healthy baby in the US in February 2024, free from complications or anomalies.
The baby turned one year old this year and has no complications.
'Yes, my insides have healed,' Alyssa said.
After her stay in India, she decided to name her baby boy 'Devendra,' which in Sanskrit means 'chief of the Gods'.
She is now planning a bachelor's degree in accounting.
Anuradha Mascarenhas is a journalist with The Indian Express and is based in Pune. A senior editor, Anuradha writes on health, research developments in the field of science and environment and takes keen interest in covering women's issues. With a career spanning over 25 years, Anuradha has also led teams and often coordinated the edition.
... Read More

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Advent to invest $175 million in Felix Pharma to acquire minority stake
Advent to invest $175 million in Felix Pharma to acquire minority stake

The Hindu

time3 hours ago

  • The Hindu

Advent to invest $175 million in Felix Pharma to acquire minority stake

Advent, a private equity investor, has announced that funds managed by it have signed a definitive agreement to invest $175 million via primary and secondary capital for a significant minority stake in Dublin, Ireland-based Felix Pharmaceuticals Pvt. Ltd. (Felix), a global Gx animal pharma player. Felix Pharma is one of the developers and manufacturer of off-patent medicines for companion animals. Felix develops, manufactures and supplies to distributors and other branded Gx players for private labelling, particularly in the U.S. Shweta Jalan, Managing Partner, Advent, said, 'Healthcare has been a long-standing focus for us, and strong parallels we see between success in human Gx globally and emerging opportunity in animal health Gx. Felix is well positioned to lead this space with its strong leadership, broad portfolio, and robust R&D and commercial capabilities.' 'Its rapid growth and high customer satisfaction make it a differentiated platform, and we are excited to support Neeraj and the Felix team in scaling it into a global franchise,' she added, Founded in 2015 by Neeraj Agrawal, a McKinsey alum, Sir Jonathan Symonds, Chair of GSK and with 30 years of experience in global pharmaceuticals, and Dr. Shumeet Banerji, ex-CEO of Booz-Allen, Felix said it has pursued strategic growth through a disciplined approach, While the company achieved its first U.S. FDA approval in 2020, it has quickly scaled to a 14 commercialised product portfolio and has several others in advanced stages of pipeline. It has a USFDA-approved oral solid facility dedicated to animal health products and an injectable facility that is expected to be ready by Q3 2025. Neeraj Agrawal, Co-Founder, Felix Pharma, said, 'As we scale in a fast-evolving market, we were looking for a partner who brings not just capital, but also deep operating expertise and the right mindset and networks to help us grow faster and stronger. Advent's strong track record in healthcare and pharma, and their close involvement in building strong businesses, gives us great confidence.'

Ahmedabad reports highest single-day rise in Covid cases; state's active case tally at 1,109
Ahmedabad reports highest single-day rise in Covid cases; state's active case tally at 1,109

Indian Express

time4 hours ago

  • Indian Express

Ahmedabad reports highest single-day rise in Covid cases; state's active case tally at 1,109

With 131 new cases of Covid in Ahmedabad — the highest single-day rise in the city — the state recorded 235 new cases on Monday. Ahmedabad Municipal Corporation's (AMC's) health officials confirmed that Monday's was the highest number of Covid cases that the city has reported in 24 hours after the fresh spate of cases. The total number of active cases in the state stands at 1,109, including 33 people who needed hospitalisation. Others are undergoing OPD-based treatment. Another 106 people, who recovered from the virus, were discharged on Monday. As per a health bulletin released by the state government, no death was reported in Gujarat on Monday. In Ahmedabad, the tally of cases has gone up to 916, including 646 active. Ahmedabad city has reported two deaths due to Covid. Among the active cases in Ahmedabad, highest were reported in the the west zone at 211, followed by the north west zone at 204, and south west zone at 114. The remaining zones have reported 50 (south zone), 25 (north zone), 24 (east zone), 18 (central zone) cases. According to the Indian SARS-CoV-2 Genomics Consortium (INSACOG), the XFG variant of the Covid-19 has been recently found in a total of 163 samples — with the highest (89) in Maharashtra, followed by Tamil Nadu (16), Kerala (15), Gujarat (11), and Andhra Pradesh, Madhya Pradesh and West Bengal (6 each). The recombinant XFG variant harbours four key spike mutations and has achieved rapid global spread following its initial detection in Canada, according to an article in The Lancet journal. In May, as many as 159 samples were detected with XFG variant, two in April, and two in June yet, data shows. India's active Covid case tally crossed the 6,000 mark, with 769 having been added to it in 48 hours, according to Union Health Ministry data released on Sunday

Luxury skincare expansion: L'Oreal acquires majority stake in Medik8; announces 1 billion Euro deal
Luxury skincare expansion: L'Oreal acquires majority stake in Medik8; announces 1 billion Euro deal

Time of India

time5 hours ago

  • Time of India

Luxury skincare expansion: L'Oreal acquires majority stake in Medik8; announces 1 billion Euro deal

Cosmetics maker L'Oreal agreed to acquire a majority stake in British skincare brand Medik8, in a strategic move to strengthen its presence in the booming skincare market. The French beauty giant announced the deal on Monday, though financial terms were not disclosed. The transaction, which sees UK-based private equity firm Inflexion selling its majority holding, reportedly values Medik8 at around 1 billion Euro, according to a source familiar with the matter. Inflexion will retain a minority share, while L'Oreal has secured the option to eventually buy out all remaining shareholders, Reuters reported. 'We are delighted to welcome Medik8 to the L'Oréal family. As a premium skincare range, with high levels of proven efficacy at an accessible price point, Medik8 perfectly complements our existing skincare portfolio,' Cyril Chaupuy, president of L'oreal Luxe said. 'This acquisition further strengthens L'Oreal's luxe portfolio, adding a premium science-backed skincare brand with a proven track record of success, with strong potential for global growth,' the company said in a statement. L'Oreal will begin consolidating Medik8's sales once the transaction officially closes. The acquisition is expected to be finalised in the coming months, pending regulatory approvals and standard closing conditions. Simon Coble, CEO of Medik8 also expressed excitement on the brand's behalf. 'I am delighted to be joining forces with a company which shares our vision for the brand's future growth and whose core values align with our deep commitment to science, innovation and above all, results without compromise. I look forward to the next stage in Medik8's journey, as we work together to bring our innovative products to a wider audience.' Founded in the UK, Medik8 has built a loyal customer base with its vitamin A-focused anti-ageing creams and serums. The brand is seen as a natural fit for L'Oreal's luxury division, which includes skincare and fragrance names such as Lancome, Aesop, and Miu Miu. Last year, sales in L'Oreal's luxe segment grew by just 2.7%, its weakest performance across divisions, as inflation pushed consumers toward more affordable alternatives. However, the unit scrored better than rival LVMH's beauty arm. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store